Cancer Fighting Effects of Aspirin

Taking aspirin blocks a key process that is associated with tumor formation, shows new study.

Taking aspirin can help to stave off bowel cancer, according to a new study. The study reveals that the painkiller blocks a key process linked to tumour formation

Regular use of aspirin is known to reduce a person's risk of developing colon cancer but the drug's tumour fighting properties have not been well understood.

Daily Intake of Aspirin Can Increase Risk of Certain Cancers in Men
Men who take daily aspirin are at higher risk of melanoma, compared those who do not consume the drug everyday.

‘Taking aspirin may improve cancer fighting strategies and keep bowel cancer away.’

Researchers at the University of Edinburgh focused on a structure found inside cells called the nucleolus.

Activation of the nucleolus is known to drive tumour formation and dysfunction has also been linked to Alzheimer's and Parkinson's.

The team at the University's Cancer Research UK Edinburgh Centre tested the effects of aspirin on cells grown in the lab and on tumour biopsies removed from colon cancer patients.

Aspirin can Reduce Effects of Obesity on Cancer
Common pain medication, aspirin can cut the effects of obesity of cancer, according to a recent study.

They found that aspirin blocks a key molecule called TIF-IA, which is essential for the nucleolus to function.

Not all colon cancer patients respond to aspirin but the researchers say their findings could help pinpoint those most likely to benefit.

Taking Aspirin Along With Celebrex can Decrease Its Cardiac Benefits
By taking aspirin along with celecoxib (Celebrex) some of Celebrex’s cardiovascular benefits can get erased, finds a new study.

Aspirin has side effects that include internal bleeding and it can cause certain types of stroke. Long term use is not recommended. The researchers say the study paves the way for the development of new, safer therapies that mimic aspirin's effects.

The research, published in Nucleic Acids Research, was funded by the Medical Research Council and the Biotechnology and Biological Sciences Research Council. Worldwide Cancer Research, Bowel and Cancer Research and The Rosetrees Trust also supported the work.

Long-Term Aspirin Use Reduces Incidence of Digestive Cancers
Colorectal, gastric and pancreatic cancer are among the top 5 cancer killers throughout Europe, with digestive cancers representing 30.1% of cancer deaths.

Dr Lesley Stark, of the Cancer Research UK Edinburgh Centre at the University of Edinburgh, said: "We are really excited by these findings as they suggest a mechanism by which aspirin may act to prevent multiple diseases. A better understanding of how aspirin blocks TIF-IA and nucleolar activity provides great promise for the development of new treatments and targeted therapy."

Source-Eurekalert